Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Chinese Medicine Granules and Slices	2.67B
Chinese Medicine Granules and Slices Growth	-8.71%
Xuebijing Injection	935.41M
Xuebijing Injection Growth	9.88%
Smart Supply Chain for Pharmaceuticals and Medical Devices	777.34M
Smart Supply Chain for Pharmaceuticals and Medical Devices Growth	8.73%
Medical Devices	343.90M
Medical Devices Growth	-10.24%
Excipients	299.46M
Excipients Growth	-12.87%
Low Molecular Weight Heparin Calcium Injection	176.07M
Low Molecular Weight Heparin Calcium Injection Growth	-38.70%
Moxifloxacin Hydrochloride and Sodium Chloride Injection	159.48M
Moxifloxacin Hydrochloride and Sodium Chloride Injection Growth	-15.82%
API	149.80M
API Growth	-4.12%
Other Products	142.81M
Other Products Growth	-24.38%
Other	129.84M
Other Growth	83.50%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
China	5.41B
China Growth	-5.82%
Overseas Regions	369.59M
Overseas Regions Growth	2.30%